Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients: a Randomized, Mono-blind Pilot Trial

NCT00599287 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT00599287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00599287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients: a Randomized, Mono-blind Pilot Trial
Lead sponsor
UMC Utrecht
Phase
Phase 3
Overall status
Terminated
Start date
February 29, 2008
Completion date
May 31, 2008
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delirium